Drug
Vvd 133214
Vvd 133214: highest development phase Phase 1, developed by Vividion Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Vividion Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| VVD-133214 NCT06004245 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Vvd 133214 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.